Data MATRIX to Offer Free EDC for All COVID-19 Trials
Data MATRIX, an eClinical software developer, has announced free access to its proprietary EDC system for sponsors running COVID-19 trials in 2020.
Recognizing the latest update of the World Health Organization with the total count of people diagnosed with coronavirus surpassing 200,000 over 8,000 of whom died, Data MATRIX’s team could not overlook the urgency which calls for the highest level of productivity and proficiency from the global life sciences community.
In response to the global outbreak of the pandemic the clinical data management software developer will provide its validated SaaS solution for clinical trials at zero cost for researchers to be able to obtain clean data and speed up the trials of such a vital value to the global community.
Given that timeline is of the highest value when dealing with pandemic, Data MATRIX EDC will provide researchers with the essential resources enabling immediate project start-up and deployment.
“During these times it is essential for everyone to practice compassion and humanity. We encourage businesses of various industries to pool their efforts and resources and do all they can in helping to combat the pandemic. We are more than happy to support researchers looking for a COVID-19 vaccine. Therefore, we are honored to provide our solutions to all the researchers and healthcare colleagues around the world to stop this unprecedented global threat. We want to step in simply because we can,” said Data MATRIX Founder, Dmitry Sharov.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
